T3	Treatment 14 21	danazol
T5	Effect 31 52	hepatocellular damage
T6	Subject 70 82	10% of women
T7	Population 70 73	10%
T8	Gender 77 82	women
T9	Drug 14 21	danazol
T4	Adverse_event 22 30	produces
E1	Adverse_event:T4